1. bookVolume 52 (2018): Issue 1 (January 2018)
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
access type Open Access

A short review of primary aldosteronism in a question and answer fashion

Published Online: 16 Feb 2018
Volume & Issue: Volume 52 (2018) - Issue 1 (January 2018)
Page range: 27 - 40
Journal Details
License
Format
Journal
eISSN
1336-0329
First Published
30 Mar 2016
Publication timeframe
4 times per year
Languages
English
Abstract

Objectives. The aim of this study was to present up to date information concerning the diagnosis and treatment of primary aldosteronism (PA). PA is the most common cause of endocrine hypertension. It has been reported up to 24% of selective referred hypertensive patients. Methods. We did a search in Pub-Med and Google Scholar using the terms: PA, hyperaldosteronism, idiopathic adrenal hyperplasia, diagnosis of PA, mineralocorticoid receptor antagonists, adrenalectomy, and surgery. We also did cross-referencing search with the above terms. We had divided our study into five sections: Introduction, Diagnosis, Genetics, Treatment, and Conclusions. We present our results in a question and answer fashion in order to make reading more interesting. Results. PA should be searched in all high-risk populations. The gold standard for diagnosis PA is the plasma aldosterone/plasma renin ratio (ARR). If this test is positive, then we proceed with one of the four confirmatory tests. If positive, then we proceed with a localizing technique like adrenal vein sampling (AVS) and CT scan. If the lesion is unilateral, after proper preoperative preparation, we proceed, in adrenalectomy. If the lesion is bilateral or the patient refuses or is not fit for surgery, we treat them with mineralocorticoid receptor antagonists, usually spironolactone. Conclusions. Primary aldosteronism is the most common and a treatable case of secondary hypertension. Only patients with unilateral adrenal diseases are eligible for surgery, while patients with bilateral and non-surgically correctable PA are usually treated by mineralocorticoid receptor antagonist (MRA). Thus, the distinction between unilateral and bilateral aldosterone hypersecretion is crucial.

Keywords

AAES, T.A.A.o.E.S. Primary hyperaldosteronism (Conn’s syndrome or aldosterone-producing adrenal tumor). Patient Education. 2016.Search in Google Scholar

Agharazii M, Douville P, Grose JH, Lebel M. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37, 1440-1443, 2001.10.1161/01.HYP.37.6.144011408392Search in Google Scholar

Ahmed AH, Gordon RD, Sukor N, Pimenta E, Stowasser M. Quality of life in patients with bilateral primary aldosteronism before and during treatment with spironolactone and/or amiloride, including a comparison with our previously published results in those with unilateral disease treated surgically. J Clin Endocrinol Metab 96, 2904-2911, 2011.10.1210/jc.2011-013821778218Open DOISearch in Google Scholar

Al-Salameh A, Cohen R, Desailloud R. Overview of the genetic determinants of primary aldosteronism. Appl Clin Genet 7, 67-79, 2014.10.2147/TACG.S45620401234524817817Open DOISearch in Google Scholar

Amar L, Lorthioir A, Azizi M, Plouin PF. Progress in primary aldosteronism. Mineralocorticoid antagonist treatment for aldosterone-producing adenoma. Eur J Endocrinol 172, R125-R129, 2015.10.1530/EJE-14-058525315875Search in Google Scholar

Armanini D, Karbowiak I, Goi A, Mantero F, Funder JW. In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay. Clin Endocrinol (Oxf) 23, 341-347, 1985.10.1111/j.1365-2265.1985.tb01090.x4064345Open DOISearch in Google Scholar

Aronova A, Fahey TJ, Zarnegar R Management of hypertension in primary aldosteronism. World J Cardiol 6, 227-233, 2014a.10.4330/wjc.v6.i5.227406212524944753Open DOISearch in Google Scholar

Aronova A, Gordon BL, Finnerty BM, Zarnegar R, Fahey TJ 3rd. Aldosteronoma resolution score predicts long-term resolution of hypertension. Surgery 156, 1387-1393, 2014b.10.1016/j.surg.2014.08.01925456916Search in Google Scholar

Assalia A, Gagner M. Laparoscopic adrenalectomy. Br J Surg 91, 1259-1274, 2004.10.1002/bjs.473815376201Search in Google Scholar

Bagrodia A, Kopp RP, Mehrazin R, Lee HJ, Liss MA, Jabaji R, Kane CJ, Wake RW, Patterson AL, Wan JY, Derweesh IH. Impact of renal surgery for cortical neoplasms on lipid metabolism. BJU Int 114, 837-843, 2014.10.1111/bju.1274424656182Search in Google Scholar

Bergstrom M, Juhlin C, Bonasera TA, Sundin A, Rastad J, Akerstrom G, Langstrom B. PET imaging of adrenal cortical tumors with the 11beta-hydroxylase tracer 11C-metomidate. J Nucl Med 41, 275-282, 2000.Search in Google Scholar

Boland GW, Dwamena BA, Jagtiani Sangwaiya M, Goehler AG, Blake MA, Hahn PF, Scott JA, Kalra MK. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology 259, 117-126, 2011.10.1148/radiol.1110056921330566Search in Google Scholar

Brown NJ. Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 14, 235-241, 2005.10.1097/01.mnh.0000165889.60254.9815821416Search in Google Scholar

Brown MJ. Primary Aldosteronism: the spectre of cure. Clin Endocrinol (Oxf) 82, 785-788, 2015.10.1111/cen.1279625891888Search in Google Scholar

Brunt LM. Minimal access adrenal surgery. Surg Endosc 20, 351-361, 2006.10.1007/s00464-004-8269-316437282Open DOISearch in Google Scholar

Brunt LM, Moley JF. Adrenal incidentaloma. World J Surg 25, 905-913, 2001.10.1007/s00268-001-0029-011572032Open DOISearch in Google Scholar

Burton TJ, Mackenzie IS, Balan K, Koo B, Bird N, Soloviev DV, Azizan EA, Aigbirhio F, Gurnell M, Brown MJ. Evaluation of the sensitivity and specificity of 11C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn’s adenomas. J Clin Endocrinol Metab 97, 100-109, 2012.10.1210/jc.2011-153722112805Search in Google Scholar

Chai YJ, Kwon H, Yu HW, Kim SJ, Choi JY, Lee KE, Youn YK. Systematic review of surgical approaches for adrenal tumors: lateral transperitoneal versus posterior retroperitoneal and laparoscopic versus robotic adrenalectomy. Int J Endocrinol 2014, 918346, 2014.10.1155/2014/918346428139825587275Search in Google Scholar

Chao CT, Wu VC, Kuo CC, Lin YH, Chang CC, Chueh SJ, Wu KD, Pimenta E, Stowasser M. Diagnosis and management of primary aldosteronism: an updated review. Ann Med 45, 375-383, 2013.10.3109/07853890.2013.78523423701121Open DOISearch in Google Scholar

Chen W, Li F, Chen D, Zhu Y, He C, Du Y, Tan W. Retroperitoneal versus transperitoneal laparoscopic adrenalectomy in adrenal tumor: a meta-analysis. Surg Laparosc Endosc Percutan Tech 23, 121-127, 2013.10.1097/SLE.0b013e3182827b5723579504Open DOISearch in Google Scholar

Chiang WF, Cheng CJ, Wu ST, Sun GH, Lin MY, Sung CC, Lin SH. Incidence and factors of post-adrenalectomy hyperkalemia in patients with aldosterone producing adenoma. Clin Chim Acta 424, 114-118, 2013.10.1016/j.cca.2013.05.01723727469Search in Google Scholar

Conder G, Rendle J, Kidd S, Misra RR. A-Z of Abdominal Radiology, Cambridge University Press, Cambridge, UK, 28-37, 2009.10.1017/CBO9780511575792Search in Google Scholar

Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med 45, 3-17, 1955.Search in Google Scholar

Constantinides VA, Christakis I, Touska P, Palazzo FF. Systematic review and meta-analysis of retroperitoneoscopic versus laparoscopic adrenalectomy. Br J Surg 99, 1639-1648, 2012.10.1002/bjs.8921Search in Google Scholar

Ctvrtlik F, Koranda P, Tichy T. Adrenal disease: a clinical update and overview of imaging. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158, 23-34, 2014.10.5507/bp.2014.010Search in Google Scholar

Dunnick NR, Korobkin M. Imaging of adrenal incidentalomas: current status. AJR Am J Roentgenol 179, 559-568, 2002.10.2214/ajr.179.3.1790559Search in Google Scholar

Dupont A. Disappearance of spironolactone-induced gynaecomastia during treatment with potassium canrenoate. Lancet 2, 731, 1985.10.1016/S0140-6736(85)92975-7Open DOISearch in Google Scholar

Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85 1863-1867, 2000.10.1210/jcem.85.5.659610843166Search in Google Scholar

Fischer E, Hanslik G, Pallauf A, Degenhart C, Linsenmaier U, Beuschlein F, Bidlingmaier M, Mussack T, Ladurner R, Hallfeldt K, Quinkler M, Reincke M. Prolonged zona glomerulosa insufficiency causing hyperkalemia in primary aldosteronism after adrenalectomy. J Clin Endocrinol Metab 97, 3965-3973, 2012.10.1210/jc.2012-223422893716Open DOISearch in Google Scholar

Fischer E, Reuschl S, Quinkler M, Rump LC, Hahner S, Bidlingmaier M, Reincke M; Participants of the German Conn’s Registry-Else Kroner-Fresenius-Hyperaldosteronism Registry. Assay characteristics influence the aldosterone to renin ratio as a screening tool for primary aldosteronism: results of the German Conn’s registry. Horm Metab Res 45, 526-531, 2013.10.1055/s-0033-134344823613013Search in Google Scholar

Fleming T, ed. 2005 Red Book: Pharmacy’s Fundamental Reference. Montvale NJ: Thomson PDR, 2005.Search in Google Scholar

Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM; Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93, 3266-3281, 2008.10.1210/jc.2008-010418552288Open DOISearch in Google Scholar

Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab 93, 3117-3123, 2008.10.1210/jc.2008-0594251508318505761Open DOISearch in Google Scholar

Giacchetti G, Ronconi V, Lucarelli G, Boscaro M, Mantero F. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol. J Hypertens 24, 737-745, 2006.10.1097/01.hjh.0000217857.20241.0f16531803Open DOISearch in Google Scholar

Gordon R. Mineralocorticoid hypertension. Lancet 344, 240-243, 1994.10.1016/S0140-6736(94)93003-1Search in Google Scholar

Gordon RD, Stowasser M, TunnyTJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21, 315-318, 1994.10.1111/j.1440-1681.1994.tb02519.xOpen DOISearch in Google Scholar

Gordon R. Primary aldosteronism. J Endocrinol Invest 18, 495-511, 1995.10.1007/BF03349761Open DOISearch in Google Scholar

Gordon RD. Diagnostic investigations in primary aldosteronism. In: Zanchetti A (ed.), Clinical Medicine Series on Hypertension. Maidenhead: McGraw-Hill International (UK) Ltd; pp. 101-114, 2001.Search in Google Scholar

Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch Intern Med 141, 1589-1593, 1981.10.1001/archinte.141.12.1589Search in Google Scholar

Hofer M. Kidneys and Adrenal Glands. Ultrasound Teaching Manual Hofer, Matthias, Thieme, 37-50, 1999.Search in Google Scholar

Hood S, Cannon J, Foo R, Brown M. Prevalence of primary hyperaldosteronism assessed by aldosterone/renin ratio and spironolactone testing. Clin Med (Lond) 5, 55-60, 2005.10.7861/clinmedicine.5-1-55Search in Google Scholar

Iacobone M, Citton M, Viel G, Rossi GP, Nitti D. Approach to the surgical management of primary aldosteronism. Gland Surg 4, 69-81, 2015.Search in Google Scholar

Ilias I, Sahdev A, Reznek RH, Grossman AB, Pacak K. The optimal imaging of adrenal tumours: a comparison of different methods. Endocr Relat Cancer 14, 587-599, 2007.10.1677/ERC-07-0045Open DOISearch in Google Scholar

Jeunemaitre X, Chatellier G, Kreft-Jais C, Charru A, DeVries C, Plouin PF, Corvol P, Menard J. Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 60, 820-825, 1987.10.1016/0002-9149(87)91030-7Open DOISearch in Google Scholar

Kaga M, Utsumi T, Tanaka T, Kono T, Nagano H, Kawamura K, Kamiya N, Imamoto T, Nihei N, Naya Y, Suzuki H, Ichikawa T. Risk of new-onset dyslipidemia after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Surg 39, 2935-2940, 2015.10.1007/s00268-015-3197-z26296835Search in Google Scholar

Kahn SL, Angle JF. Adrenal vein sampling. Tech Vasc Interv Radiol 13, 110-125, 2010.10.1053/j.tvir.2010.02.00620540920Search in Google Scholar

Kem DC, Weinberger MH, Mayes DM, Nugent CA. Saline suppression of plasma aldosterone in hypertension. Arch Intern Med 128, 380-386, 1971.10.1001/archinte.128.3.380Search in Google Scholar

Kline GA. Primary Aldosteronism: unnecessary complexity in definition and diagnosis as a barrier to wider clinical care. Clin Endocrinol (Oxf) 82, 779-784, 2015.10.1111/cen.1279825891981Search in Google Scholar

Kucharz EJ. [Michal Litynski--a forgotten author of the first description on primary hyperaldosteronism]. Pol Arch Med Wewn 117, 57-58, 2007.10.20452/pamw.79Search in Google Scholar

Lafferty AR, Torpy DJ, Stowasser M, Taymans SE, Lin JP, Huggard P, Gordon RD, Stratakis CA. A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet 37, 831-835, 2000.10.1136/jmg.37.11.831173446811073536Search in Google Scholar

Lee J, El-Tamer M, Schifftner T, Turrentine FE, Henderson WG, Khuri S, Hanks JB, Inabnet WB 3rd. Open and laparoscopic adrenalectomy: analysis of the National Surgical Quality Improvement Program. J Am Coll Surg 206, 953-961, 2008.10.1016/j.jamcollsurg.2008.01.01818471733Search in Google Scholar

Letavernier E, Peyrard S, Amar L, Zinzindohoue F, Fiquet B, Plouin PF. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens 26, 1816-1823, 2008.10.1097/HJH.0b013e3283060f0c18698217Open DOISearch in Google Scholar

Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31, 445-450, 1998.10.1161/01.HYP.31.1.445Open DOISearch in Google Scholar

Mantero F, Fallo F, Opocher G, Armanini D, Boscaro M, Scaroni C. Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. Clin Sci (Lond) 61, 289s-293s, 1981.10.1042/cs061289s7032817Open DOISearch in Google Scholar

Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85, 637-644, 2000.10.1210/jcem.85.2.637210690869Search in Google Scholar

Mattsson C, Young WF. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Nephrol 2, 198-208, 2006.10.1038/ncpneph015116932426Open DOISearch in Google Scholar

McCurley A, Pires PW, Bender SB, Aronovitz M, Zhao MJ, Metzger D, Chambon P, Hill MA, Dorrance AM, Mendelsohn ME, Jaffe IZ. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat Med 18, 1429-1433, 2012.10.1038/nm.2891349108522922412Open DOISearch in Google Scholar

McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 73, 952-957, 1991.10.1210/jcem-73-5-9521939533Search in Google Scholar

Melby JC, Spark RF, Dale SL, Egdahl RH, Kahn PC. Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein catheterization. N Engl J Med 277, 1050-1056, 1967.10.1056/NEJM1967111627720026059584Search in Google Scholar

Mengozzi G, Rossato D, Bertello C, Garrone C, Milan A, Pagni R, Veglio F, Mulatero P. Rapid cortisol assay during adrenal vein sampling in patients with primary aldosteronism. Clin Chem 53, 1968-1971, 2007.10.1373/clinchem.2007.09208017901112Search in Google Scholar

Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45, 1243-1248, 2005.10.1016/j.jacc.2005.01.01515837256Open DOISearch in Google Scholar

Monticone S, Hattangady NG, Penton D, Isales CM, Edwards MA, Williams TA, Sterner C, Warth R, Mulatero P, Rainey WE. A novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III. J Clin Endocrinol Metab 98, E1861-E1865, 2013.10.1210/jc.2013-2428381626524037882Search in Google Scholar

Moraitis A, Stratakis C. Adrenocortical causes of hypertension. Int J Hypertens 2011, 624691, 2011.10.4061/2011/624691305702921423682Search in Google Scholar

Mulatero P, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40, 897-902, 2002.10.1161/01.HYP.0000038478.59760.4112468576Open DOISearch in Google Scholar

Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF Jr. Increased diagnosis of primary aldosteronism, including surgically correctable forms in centers from five continents. J Clin Endocrinol Metab 89, 1045-1050, 2004.10.1210/jc.2003-03133715001583Search in Google Scholar

Mulatero P, Monticone S, Bertello C, Viola A, Tizzani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F, Veglio F. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 98, 4826-4833, 2013.10.1210/jc.2013-280524057288Open DOISearch in Google Scholar

Papierska L, Cichocki A, Sankowski AJ, Cwikla JB. Adrenal incidentaloma imaging - the first steps in therapeutic management. Pol J Radiol 78, 47-55, 2013.10.12659/PJR.889541390850724505223Search in Google Scholar

Piecha G, Adamczak M, Ritz E. Dyslipidemia in chronic kidney disease. Pol Arch Med Wewn 119, 487-492, 2009.10.20452/pamw.745Search in Google Scholar

Powlson AS, Gurnell M, Brown MJ. Nuclear imaging in the diagnosis of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes 22, 150-156, 2015.10.1097/MED.0000000000000148Search in Google Scholar

Probst KA, Ohlmann CH, Saar M, Siemer S, Stoeckle M, Janssen M. Robot-assisted vs open adrenalectomy: evaluation of cost-effectiveness and peri-operative outcome. BJU Int 118, 952-957, 2016.10.1111/bju.13529Open DOISearch in Google Scholar

Ramsay LE, Hettiarachchi J, Fraser R, Morton JJ. Amiloride, spironolactone, and potassium chloride in thiazidetreated hypertensive patents. Clin Pharmacol Ther 27, 533-543, 1980.10.1038/clpt.1980.75Open DOISearch in Google Scholar

Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S; Participants of German Conn’s Registry. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab 94, 869-875, 2009.10.1210/jc.2008-1851Open DOISearch in Google Scholar

Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15, 896-902, 2002.10.1016/S0895-7061(02)02969-2Open DOISearch in Google Scholar

Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F; PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48, 2293-2300, 2006a.10.1016/j.jacc.2006.07.05917161262Search in Google Scholar

Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M, Matterello MJ, Montemurro D, Palumbo G, Rizzoni D, Rossi E, Pessina AC, Mantero F; PAPY Study Participants. Renal damage in primary aldosteronism results of the PAPY study. Hypertension 48, 232-238, 2006b.10.1161/01.HYP.0000230444.01215.6a16801482Open DOISearch in Google Scholar

Rossi GP, Ganzaroli C, Miotto D, De Toni R, Palumbo G, Feltrin GP, Mantero F, Pessina AC. Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients. J Hypertens 24, 371-379, 2006c.10.1097/01.hjh.0000202818.10459.9616508586Open DOISearch in Google Scholar

Rossi GP, Belfiore A, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Palumbo G, Rizzoni D, Rossi E, Agabiti-Rosei E, Pessina AC, Mantero F; Primary Aldosteronism Prevalence in Italy Study Investigators. Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension 50, 424-443, 2007.10.1161/HYPERTENSIONAHA.107.09182717592070Open DOISearch in Google Scholar

Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 26, 989-997, 2008.10.1097/HJH.0b013e3282f9e66a18398342Open DOISearch in Google Scholar

Schirpenbach C, Seiler L, Maser-Gluth C, Rudiger F, Nickel C, Beuschlein F, Reincke M. Confirmatory testing in normokalaemic primary aldosteronism: the value of saline infusion test and urinary aldosterone metabolites. Eur J Endocrinol 154, 865-873, 2006.10.1530/eje.1.0216416728547Search in Google Scholar

Schirpenbach C, Reincke M. Primary aldosteronism: current knowledge and controversies in Conn’s syndrome. Nat Clin Pract Endocrinol Metab 3, 220-227, 2007.10.1038/ncpendmet043017315030Open DOISearch in Google Scholar

Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 51, 386-394, 2005.10.1373/clinchem.2004.04178015681560Search in Google Scholar

Shen WT, Lim RC, Siperstein AE, Clark OH, Schecter WP, Hunt TK, Horn JK, Duh QY. Laparoscopic vs open adrenalectomy for the treatment of primary hyperaldosteronism. Arch Surg 134, 628-632, 1999.10.1001/archsurg.134.6.62810367872Search in Google Scholar

Sica DA. Pharmacokinetics and pharmacodynamics of mineralocorticoid blocking agents and their effects on potassium homeostasis. Heart Fail Rev 10, 23-29, 2005.10.1007/s10741-005-2345-115947888Search in Google Scholar

So A, Duffy DL, Gordon RD, Jeske YW, Lin-Su K, New MI, Stowasser M. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens 23, 1477-1484, 2005.10.1097/01.hjh.0000174299.66369.2616003173Search in Google Scholar

Spyridonidis TJ, Apostolopoulos DJ. Is there a role for Nuclear Medicine in diagnosis and management of patients with primary aldosteronism? Hell J Nucl Med 16, 134-139, 2013.Search in Google Scholar

Steichen O, Lorthioir A, Zinzindohoue F, Plouin PF, Amar L. Outcomes of drug-based and surgical treatments for primary aldosteronism. Adv Chronic Kidney Dis 22, 196-203, 2015.10.1053/j.ackd.2014.10.00325908468Search in Google Scholar

Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM. High rate of detection of primary aldosteronism, including surgically treatable forms, after a “non-selective” screening of hypertensive patients. J Hypertens 21, 2149-2157, 2003.10.1097/00004872-200311000-0002514597859Search in Google Scholar

Stowasser M, Gordon RD. Primary aldosteronism--careful investigation is essential and rewarding. Mol Cell Endocrinol 217, 33-39, 2004.10.1016/j.mce.2003.10.00615134798Search in Google Scholar

Stowasser M, Sharman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH. Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 90, 5070-5076, 2005.10.1210/jc.2005-068115941863Search in Google Scholar

Stowasser M, Ahmed A, Pimenta E, Taylor PJ, Gordon RD. Factors affecting the aldosterone/renin ratio. Horm Metab Res 44, 170-176, 2012.10.1055/s-0031-129546022147655Search in Google Scholar

Szolar DH, Korobkin M, Reittner P, Berghold A, Bauernhofer T, Trummer H, Schoellnast H, Preidler KW, Samonigg H. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234, 479-485, 2005.10.1148/radiol.234203187615671003Search in Google Scholar

TAIPAI Study Group, Wu VC, Chueh SC, Chang HW, Lin LY, Liu KL, Lin YH, Ho YL, Lin WC, Wang SM, Huang KH, Hung KY, Kao TW, Lin SL, Yen RF, Chen YM, Hsieh BS, Wu KD. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma. Am J Kidney Dis 54, 665-673, 2009.10.1053/j.ajkd.2009.06.01419628318Open DOISearch in Google Scholar

Takeda M, Go H, Imai T, Nishiyama T, Morishita H. Laparoscopic adrenalectomy for primary aldosteronism: report of initial ten cases. Surgery 115, 621-625, 1994.Search in Google Scholar

Tang K, Li H, Xia D, Yu G, Guo X, Guan W, Xu H, Ye Z. Robot-assisted versus laparoscopic adrenalectomy: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 25, 187-195, 2015.10.1089/lap.2014.043125763475Search in Google Scholar

Thompson GB, Young WF Jr. Adrenal incidentaloma. Curr Opin Oncol 15, 84-90, 2003.10.1097/00001622-200301000-0001312490767Open DOISearch in Google Scholar

Tomaschitz A, Pilz S. Aldosterone to renin ratio--a reliable screening tool for primary aldosteronism? Horm Metab Res 42, 382-391, 2010.10.1055/s-0030-124832620225167Open DOISearch in Google Scholar

Utsumi T, Kawamura K, Imamoto T, Nagano H, Tanaka T, Kamiya N, Nihei N, Naya Y, Suzuki H, Ichikawa T. Preoperative masked renal damage in Japanese patients with primary aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. Int J Urol 20, 685-691, 2013.10.1111/iju.1202923190329Open DOISearch in Google Scholar

Vaziri N. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol 290, F262-F272, 2006.10.1152/ajprenal.00099.200516403839Search in Google Scholar

Walz MK, Alesina PF, Wenger FA, Deligiannis A, Szuczik E, Petersenn S, Ommer A, Groeben H, Peitgen K, Janssen OE, Philipp T, Neumann HP, Schmid KW, Mann K. Posterior retroperitoneoscopic adrenalectomy--results of 560 procedures in 520 patients. Surgery 140, 943-950, 2006.10.1016/j.surg.2006.07.03917188142Search in Google Scholar

Weiner ID. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. Semin Nephrol 33, 265-276, 2013.10.1016/j.semnephrol.2013.04.007374839023953804Open DOISearch in Google Scholar

White ML, Gauger PG, Doherty GM, Cho KJ, Thompson NW, Hammer GD, Miller BS. The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. Surgery 144, 926-933, 2008.10.1016/j.surg.2008.07.02519040999Search in Google Scholar

Worth PJ, Kunio NR, Siegfried I, Sheppard BC, Gilbert EW. Characteristics predicting clinical improvement and cure following laparoscopic adrenalectomy for primary aldosteronism in a large cohort. Am J Surg 210, 702-709, 2015.10.1016/j.amjsurg.2015.05.03326323999Search in Google Scholar

Wu VC, Yang SY, Lin JW, Cheng BW, Kuo CC, Tsai CT, Chu TS, Huang KH, Wang SM, Lin YH, Chiang CK, Chang HW, Lin CY, Lin LY, Chiu JS, Hu FC, Chueh SC, Ho YL, Liu KL, Lin SL, Yen RF, Wu KD; TAIPAI Study Group. Kidney impairment in primary aldosteronism. Clin Chim Acta 412, 1319-1325, 2011.10.1016/j.cca.2011.02.01821345337Search in Google Scholar

Young WF Jr. Primary aldosteronism: management issues. Ann N Y Acad Sci 970, 61-76, 2002.10.1111/j.1749-6632.2002.tb04413.x12381542Search in Google Scholar

Young WF Jr. Minireview: primary aldosteronism--changing concepts in diagnosis and treatment. Endocrinology 144, 2208-2213, 2003a.10.1210/en.2003-027912746276Search in Google Scholar

Young WF Jr. Adrenalectomy for primary aldosteronism; authors’ reply. Ann Intern Med 138, 157-159, 2003b.10.7326/0003-4819-138-2-200301210-0002312529104Search in Google Scholar

Young WF, Stanson AW, Thompson GB, Grant CS, Farley DR, van Heerden JA. Role for adrenal venous sampling in primary aldosteronism. Surgery 136, 1227-1235, 2004.10.1016/j.surg.2004.06.05115657580Search in Google Scholar

Young WF Jr. Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356, 601-610, 2007.10.1056/NEJMcp06547017287480Search in Google Scholar

Young WF, Stanson AW. What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism? Clin Endocrinol (Oxf) 70, 14-17, 2009.10.1111/j.1365-2265.2008.03450.x19128364Search in Google Scholar

Zarnegar R, Young WF Jr, Lee J, Sweet MP, Kebebew E, Farley DR, Thompson GB, Grant CS, Clark OH, Duh QY. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247, 511-518, 2008.10.1097/SLA.0b013e318165c07518376197Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo